Lyell Immunopharma
Operator of a biotechnology company that develops cellular therapies to cure cancer.
HQ location
San Francisco, United States
Website
Launch date
Employees
Market cap
$217m
Enterprise value
($13m)
Share price
$11.10 LYEL
Recent deals
Authorizing premium user...